1. Home
  2. PLUR vs NTZ Comparison

PLUR vs NTZ Comparison

Compare PLUR & NTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLUR
  • NTZ
  • Stock Information
  • Founded
  • PLUR 2001
  • NTZ 1959
  • Country
  • PLUR Israel
  • NTZ Italy
  • Employees
  • PLUR N/A
  • NTZ N/A
  • Industry
  • PLUR Biotechnology: Biological Products (No Diagnostic Substances)
  • NTZ Home Furnishings
  • Sector
  • PLUR Health Care
  • NTZ Consumer Discretionary
  • Exchange
  • PLUR Nasdaq
  • NTZ Nasdaq
  • Market Cap
  • PLUR 36.9M
  • NTZ 37.2M
  • IPO Year
  • PLUR N/A
  • NTZ 1993
  • Fundamental
  • Price
  • PLUR $3.91
  • NTZ $3.25
  • Analyst Decision
  • PLUR Strong Buy
  • NTZ
  • Analyst Count
  • PLUR 1
  • NTZ 0
  • Target Price
  • PLUR $12.00
  • NTZ N/A
  • AVG Volume (30 Days)
  • PLUR 10.5K
  • NTZ 1.9K
  • Earning Date
  • PLUR 11-11-2025
  • NTZ 04-13-2023
  • Dividend Yield
  • PLUR N/A
  • NTZ N/A
  • EPS Growth
  • PLUR N/A
  • NTZ N/A
  • EPS
  • PLUR N/A
  • NTZ N/A
  • Revenue
  • PLUR $1,336,000.00
  • NTZ $337,653,480.00
  • Revenue This Year
  • PLUR $97.38
  • NTZ N/A
  • Revenue Next Year
  • PLUR $293.97
  • NTZ N/A
  • P/E Ratio
  • PLUR N/A
  • NTZ N/A
  • Revenue Growth
  • PLUR 309.82
  • NTZ N/A
  • 52 Week Low
  • PLUR $3.33
  • NTZ $2.15
  • 52 Week High
  • PLUR $7.13
  • NTZ $6.27
  • Technical
  • Relative Strength Index (RSI)
  • PLUR 41.69
  • NTZ 51.27
  • Support Level
  • PLUR $3.60
  • NTZ $2.70
  • Resistance Level
  • PLUR $4.09
  • NTZ $3.41
  • Average True Range (ATR)
  • PLUR 0.18
  • NTZ 0.15
  • MACD
  • PLUR -0.02
  • NTZ 0.04
  • Stochastic Oscillator
  • PLUR 30.69
  • NTZ 56.34

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.

Share on Social Networks: